SecBot SecBot
8-K ·Filed May 21, 2026

HIMS

Hims & Hers Health, Inc.
NEUTRAL
Impact 5/10
Horizonweeks Processed5mo ago SEC0001193125-26-234847
Killer combo: Material agreement + unregistered equity (likely PIPE/convertible)
Actionable Insight • Neutral

The convertible note issuance provides $402.5M in capital with zero coupon, but adds leverage and potential dilution. The capped call transactions reduce but do not eliminate dilution risk. Monitor stock price relative to conversion price (~$29.53) — if HIMS trades above that level, conversion becomes in-the-money and dilution risk increases. The notes are not redeemable until June 2029, so near-term conversion is unlikely unless stock price triggers conversion conditions (130% of conversion price for 20 of 30 days). The 0% coupon is favorable for the company but reflects high growth expectations. Watch for use of proceeds disclosure in subsequent filings.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
HIMS ▲ +15.33% at T+60d
NEUTRAL call +15.33% · α vs SPY +12.14% · entry $23.75 → $27.39
Entry = T+0 close
May 21, 2026
via day close
T+1d
+0.42%
call +0.42% · α -0.16%
$23.85
settled 5mo ago
T+5d
+16.88%
call +16.88% · α +15.21%
$27.76
settled 5mo ago
T+20d
+41.01%
call +41.01% · α +42.43%
$33.49
settled 4mo ago
T+60d
+15.33%
call +15.33% · α +12.14%
$27.39
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Hims & Hers Health issued $402.5M aggregate principal amount of 0.00% convertible senior notes due 2032, and concurrently entered into capped call transactions with dealers to reduce potential dilution upon conversion. The net proceeds were not specified in the filing, but the offering size is $402.5M, with an initial conversion rate of 33.8590 shares per $1,000 principal (conversion price ~$29.53). The notes bear no regular interest, mature June 1, 2032, and are redeemable at the company's option on or after June 6, 2029 if stock price exceeds 130% of conversion price for 20 of 30 trading days. Holders can require repurchase upon a fundamental change at par plus accrued interest. The capped call transactions effectively cap the conversion premium at a stated cap price, limiting dilution for the company.

Key Financial Metrics

Offering Size
$402.5M

Key Facts

  • $402.5M aggregate principal amount of 0.00% convertible senior notes due 2032 issued
  • Initial conversion rate of 33.8590 shares per $1,000 principal (conversion price ~$29.53)
  • Notes mature June 1, 2032, bear no regular interest
  • Company may redeem notes on/after June 6, 2029 if stock price exceeds 130% of conversion price for 20 of 30 trading days
  • Holders may require repurchase upon a fundamental change at par plus accrued interest
  • Company entered into capped call transactions to offset dilution from conversion
  • Shoe option for additional $52.5M notes was exercised (per additional call option confirmation dated May 19, 2026)
  • Net proceeds not disclosed in filing documents

Financial Impact

$402.5M convertible note issuance with capped call hedge; dilution potential partially offset by hedge

dilutiondebtshare count

Risk Factors

  • Potential dilution of ~33.9 shares per $1,000 note if fully converted (partially hedged by capped calls)
  • Added leverage with $402.5M in new debt, though zero-coupon reduces cash burden
  • Stock price below conversion price could limit conversion and leave debt outstanding until 2032
  • Capped call transactions may not fully offset dilution if stock price exceeds cap price

Market Snapshot

Exchange
NYSE
Sector
Services-Offices & Clinics of Doctors of Medicine
Analyst Consensus
43% bullish (23 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-234847
Document: d264371dex101.htm0001193125-26-234847
Document: d264371dex102.htm0001193125-26-234847
18 reports for HIMS
Performance horizon
60% Hit rate @ T+20 3 of 5 directional calls Went positive at some point 4 of 5 best @ T+20▲ +36.57%Jun 2, 2026
Filters
Rows
Reports for HIMS — sortable, filterable
TypeNow
Oct 7, 2026
18d ago
8-K
NEUTRAL ★ 3/10
$28.06awaiting T+20—$27.60 (−1.62%)
Sep 23, 2026
4w ago
Insider Cluster
BEARISH ★ 5/10
$29.28 $29.13▲ +0.51%▲ +0.09%$27.60 (+5.72%)
Sep 18, 2026
5w ago
Insider Cluster
BEARISH ★ 4/10
$29.35 $28.15▲ +4.09%▲ +3.18%$27.60 (+5.95%)
Sep 17, 2026
5w ago
Insider Cluster
BEARISH ★ 4/10
$27.99 $28.07▼ −0.29%▼ −0.08%$27.60 (+1.38%)
Aug 20, 2026
9w ago
Insider Cluster
NEUTRAL ★ 3/10
$33.78 $29.35▼ −13.11%▼ −14.13%$27.60 (−18.28%)
Aug 20, 2026
9w ago
Insider Cluster
NEUTRAL ★ 3/10
$33.78 $29.35▼ −13.11%▼ −14.13%$27.60 (−18.28%)
Aug 18, 2026
9w ago
Insider Cluster
NEUTRAL ★ 3/10
$31.09 $27.89▼ −10.29%▼ −9.45%$27.60 (−11.21%)
Aug 10, 2026
10w ago
8-K
MIXED ★ 7/10
$30.51 $27.90▼ −8.55%▼ −7.50%$27.60 (−9.52%)
Jul 1, 2026
16w ago
8-K
NEUTRAL ★ 5/10
$36.80 $27.04▼ −26.52%▼ −26.11%$27.60 (−24.99%)
Jun 17, 2026
18w ago
Insider Cluster
NEUTRAL ★ 2/10
$35.47 $33.68▼ −5.05%▼ −5.58%$27.60 (−22.17%)
Showing 10 of 18

US Market Status

Market Closed — Opens Tue (17h 28m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 21, 2026